Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 50021388
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM11639(Celecoxib | CLX | Celebrex | 4-[5-(4-methylphenyl)...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224101(4-(3-phenyl-5-p-tolyl-1H-pyrazol-1-yl)benzenesulfo...)
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224109(Celecoxib | 1-(4-(methylsulfonyl)phenyl)-5-p-tolyl...)
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50057568(4-(3-(trifluoromethyl)-5-(4-(trifluoromethyl)pheny...)
Affinity DataIC50: 1.70E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224112(2-[4-(5-(4-trifluoromethylphenyl)-3-trifluoromethy...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224110(1-(4-(methylsulfinyl)phenyl)-5-p-tolyl-3-(trifluor...)
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224102(4-[3-trifluoromethyl-5-(4-methylphenyl)-1H-pyrazol...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224103(ethyl 4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224104(4-(3-(trifluoromethyl)-5-(4-(trifluoromethyl)pheny...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224106(1-(4-sulfamoyl-phenyl)-5-p-tolyl-1H-pyrazole-3-car...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224105(1,5-dip-tolyl-3-(trifluoromethyl)-1H-pyrazole | 1,...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224108(2-[4-(5-(4-methylphenyl)-3-trifluoromethyl-1H-pyra...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224107(ethyl 4-[5-(4-Trifluoromethylphenyl)-3-trifluorome...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D MöLndal

Curated by ChEMBL
LigandPNGBDBM50224111(4-[5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazol...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9 by fluorescence inhibition assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed